Stay updated with breaking news from Izana Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may offer benefit to some patients hospitalised with COVID-19 pneumonia.
A proof-of-concept trial led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may offer benefit some patients hospitalized with COVID-19 pneumonia.
The antibody is already in late-stage trials to treat rheumatoid arthritis.
The antibody is already in late-stage trials to treat rheumatoid arthritis.
The antibody is already in late-stage trials to treat rheumatoid arthritis.